YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
2.450
-0.010 (-0.41%)
At close: Jul 17, 2026, 4:00 PM EDT
2.470
+0.020 (0.82%)
After-hours: Jul 17, 2026, 7:09 PM EDT
YD Bio Market Cap
YD Bio has a market cap or net worth of $172.28 million as of July 17, 2026. Its market cap has increased by 314.72% in one year.
Market Cap
172.28M
Enterprise Value
169.17M
1-Year Change
314.72%
Ranking
Category
Stock Price
$2.45
ChartMarket Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $172.28M, an increase of 16.13%. That is a compound annual growth rate of 2.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 172.28M | -79.90% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corbus Pharmaceuticals Holdings | 166.94M |
| Alector | 166.54M |
| Oramed Pharmaceuticals | 166.16M |
| PepGen | 166.01M |
| Equillium | 165.65M |
| Acumen Pharmaceuticals | 160.35M |
| Cibus | 158.77M |
| LENZ Therapeutics | 156.46M |